EP3528771A1 - Methods and kits for removing calculus using a metal ion and bicarbonate - Google Patents
Methods and kits for removing calculus using a metal ion and bicarbonateInfo
- Publication number
- EP3528771A1 EP3528771A1 EP17768326.5A EP17768326A EP3528771A1 EP 3528771 A1 EP3528771 A1 EP 3528771A1 EP 17768326 A EP17768326 A EP 17768326A EP 3528771 A1 EP3528771 A1 EP 3528771A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- component
- tooth
- ion
- calculus
- precursor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/79—Initiators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
Definitions
- Dental calculus may lead to periodontal diseases including gingivitis and periodontitis.
- the existing methods of removing dental calculus rely upon mechanical means such as scaling by trained dental professionals.
- Such existing removal procedures can be painful and uncomfortable for patients.
- the existing removal procedures can put a significant physical burden on the hygienist, often times leading to muscular and repetitive movement ailments (e.g., carpal tunnel syndrome).
- a significant amount of time during the dental prophylaxis procedure is allocated to calculus removal. It is therefore desirable to create a better solution to remove calculus.
- Some aspects of the present disclosure provide a method of removing calculus from a tooth.
- the method can include applying a component A to the tooth, wherein component A includes: a metal ion selected from the group of lithium ion (Li + ), magnesium ion (Mg 2+ ), calcium ion (Ca 2+ ), a precursor thereto, and a combination thereof; and an aprotic base having a pKb in water of greater than 15.4, or a precursor thereto; applying a component B to the tooth, wherein component B includes a bicarbonate ion or a precursor thereto; wherein components A and B are applied simultaneously or sequentially to the tooth, thereby generating a gas to soften and/or loosen at least part of the calculus on the tooth; and removing at least a part of the calculus from the tooth.
- component A includes: a metal ion selected from the group of lithium ion (Li + ), magnesium ion (Mg 2+ ), calcium ion (
- kits of parts for removing calculus from a tooth can include: a component A including: a metal ion selected from the group of lithium ion (Li + ), magnesium ion (Mg 2+ ), calcium ion (Ca 2+ ), a precursor thereto, and a combination thereof; and an aprotic base having a pKb in water of greater than 15.4, or a precursor thereto; a component B comprising a bicarbonate ion or a precursor thereto; and instructions for applying components A and B to the tooth simultaneously or sequentially, thereby generating a gas to soften and/or loosen at least part of the calculus on the tooth, and for removing at least a part of the calculus from the tooth.
- a component A including: a metal ion selected from the group of lithium ion (Li + ), magnesium ion (Mg 2+ ), calcium ion (Ca 2+ ), a precursor thereto, and a combination thereof; and an aprotic base
- phrases "at least one of and “comprises at least one of followed by a list refers to any one of the items in the list and any combination of two or more items in the list.
- preventing and/or treating an affliction means preventing, treating, or both treating and preventing further afflictions).
- any lower limit of a range can be paired with any upper limit of a range.
- Such numerical ranges also are meant to include all numbers subsumed within the range (for example, 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, 5, and so forth).
- Dental calculus (also referred to as dental tartar) is defined as mineralized dental biofilm filled with crystals of various calcium phosphates or dental plaque that has partially or completely calcified. It may be caused by the continual accumulation of minerals from fluids in the oral environment on plaque on the teeth. Dental calculus is a common oral condition afflicting humans and a variety of animal species and the presence of dental calculus may lead to periodontal diseases. The existing methods of removing dental calculus, which rely upon mechanical means such as scaling, are time consuming and laborious for dental professionals, and can be a painful and unpleasant experience for patients.
- the present disclosure generally relates to methods and kits of removing calculus from a tooth.
- the method can include applying a component A to the tooth, applying a component B to the tooth, wherein components A and B are applied simultaneously or sequentially to the tooth, thereby generating a gas to soften and/or loosen at least part of the calculus on the tooth; and removing at least a part of the calculus from the tooth.
- component A is applied before or after component B is applied.
- the method of the present disclosure can, for example, provide an easier removal of dental calculus.
- the method of the present disclosure can reduce the time of calculus removal. For example, after the application of component A and component B, removing the calculus is easier and quicker.
- the method of the present disclosure can enable improved procedural efficiency, opportunities for more patients, additional time for other procedures and increased rest periods for the dental professional.
- component A includes: a metal ion selected from the group of lithium ion (Li + ), magnesium ion (Mg 2+ ), calcium ion (Ca 2+ ), a precursor thereto, and a combination thereof; and an aprotic base having a pKb in water of greater than 15.4, or a precursor thereto.
- the aprotic base often is a halogen-containing anion.
- the aprotic base is a halide (e.g., iodide, bromide, and chloride).
- the aprotic base of component A includes triflate ion (OTf ), iodide ion ( ⁇ ), perchlorate ion (CIO4 ), bromide ion (Br ), chloride ion (CI ), or a combination thereof.
- a precursor of a metal ion of component A includes a solid salt (e.g., a lithium halide, a magnesium halide, a calcium halide, or a combination thereof).
- a precursor of an aprotic base having a pKb in water of greater than 15.4 includes a solid salt (e.g., a lithium halide, a magnesium halide, a calcium halide, a sodium halide, a sodium triflate, a sodium perchlorate, or a combination thereof) .
- component A includes a lithium halide, a magnesium halide, a calcium halide, or a combination thereof.
- component A includes LiCl, MgCh, CaCh, or a combination thereof.
- component A could include lithium nitrate and sodium chloride.
- component B could include a bicarbonate salt such as potassium bicarbonate or sodium bicarbonate. The key is that the lithium ion, chloride ion, and bicarbonate ion are all present on a tooth.
- component A is a solid when applied to the tooth that is at least partially dissolved upon mixing component A and component B on the tooth.
- component A is an aqueous solution when applied to the tooth.
- the aqueous solution comprises greater than 1 M of a metal salt that includes the metal ion.
- the aqueous solution can contain greater than 1.5 M, greater than 2 M, or greater than 2.5 M of the metal salt that includes the metal ion.
- the aqueous solution includes a saturated solution of the metal ion, or the metal ion at a concentration up to the solubility limit of the metal salt. The concentration of component A is prior to mixing with component B.
- component A is an aqueous solution when applied to the tooth and the aqueous solution comprises greater than 1 M of a salt containing the aprotic base.
- the salt of the aprotic base often contains either one or two moles of aprotic base per mole of the salt.
- the aqueous solution can contain greater than 1 M of the aprotic base or greater than 2 M of the aprotic base.
- the aqueous solution includes a saturated solution of the aprotic base, or the aprotic base at a concentration up to the solubility limit of the salt of the aprotic base.
- the salt of the aprotic base is the same as the metal salt. The concentration of component A is prior to mixing with component B.
- component B includes a bicarbonate ion or a precursor thereto.
- a precursor of a bicarbonate ion of component B includes a solid salt (e.g., potassium bicarbonate (KHCO3) and sodium bicarbonate (NaHCC )).
- a precursor to a bicarbonate ion includes a carbonate and an acid, which can form the bicarbonate.
- component B can include a mixture of sodium carbonate plus hydrochloric acid, which forms sodium chloride and sodium bicarbonate.
- component B is a solid when applied to the tooth that is at least partially dissolved upon mixing component A and component B on the tooth.
- component B is an aqueous solution when applied to the tooth.
- the aqueous solution includes greater than 0.5 M of a bicarbonate ion.
- the aqueous solution can have a concentration greater than 1 M, greater than 1.5 M, or greater than 2 M bicarbonate ion.
- the aqueous solution includes a saturated solution of the bicarbonate ion, or the bicarbonate ion at a concentration up to the solubility limit of the bicarbonate salt, or up to 3 M bicarbonate ion.
- the concentration of component B is prior to mixing with component A.
- a gas is generated, thereby softening and/or loosening the calculus on the tooth.
- This gas is believed to be CO2, although this is not a limitation of the present disclosure.
- the generated gas can, for example, weaken the adhesion between the calculus and tooth surface so that the calculus can be removed easily after relatively short exposure times to component A and component B.
- the generated gas can soften and/or loosen the calculus so that the removal of the calculus, for example, by hand scaling is much easier. For instance, the calculus can be removed in a shorter time or with a less force.
- component A is applied to the tooth surface before or after component B is applied to the tooth surface.
- component A is applied at least 30 seconds before or after component B is applied.
- Either component A or component B can be (independently) in any form suitable for oral cavity delivery, such as in the form of aqueous solutions (e.g., a rinse), a gel, a paste, or a powder.
- aqueous solutions e.g., a rinse
- component A and component B can be applied both as rinses.
- component A can be applied as a gel and component B can be applied as a rinse.
- component A or component B is applied for a period of less than 1 hour, less than 30 minutes, less than 10 minutes, less than 5 minutes, less than 2 minutes, less than 1 minute, or less than 30 seconds, particularly before applying the other component. In some of these embodiments, component A or component B is applied for 10 minutes, 5 minutes, 2 minutes, 1 minute, 30 seconds, 15 seconds, or a range between and including any two of these values. In some embodiments, both component A and component B are each applied for a period of less than 1 hour, less than 30 minutes, less than 10 minutes, less than 5 minutes, less than 2 minutes, or less than 1 minute.
- At least a part of the calculus can be removed from the tooth by a suitable mechanical means, e.g., scaling (such as using a dental scaler), brushing, swabbing, wiping, ultrasonic scaling, air polishing or jetted water.
- a suitable mechanical means e.g., scaling (such as using a dental scaler), brushing, swabbing, wiping, ultrasonic scaling, air polishing or jetted water.
- the part of the calculus may be removed by mechanical means other than tooth brushing, for example, by a dental scaler.
- the removing step occurs within 1 day, 12 hours, 6 hours, 3 hours, 1 hour, 30 minutes, 10 minutes, 5 minutes, 2 minutes, 1 minute, 30 seconds, or 15 seconds, after the applying steps.
- the removing step lasts for a period less than 10 minutes, less than 5 minutes, less than 2 minutes, or less than 1 minute. In other embodiments, the removing step lasts 10 minutes, 5 minutes, 2 minutes, 1 minute, 30 seconds, or a range between and including any two of these values.
- the method of the present disclosure can, for example, provide an easier and/or quicker removal of the calculus.
- the applying steps and removing step are all completed in less than 1 day, less than 12 hours, less than 6 hours, less than 3 hours, less than 1 hour, less than 30 minutes, less than 10 minutes, less than 5 minutes, less than 2 minutes, or less than 1 minute.
- first solid Li CI in powder form is applied to a tooth surface that includes calculus. After one minute, a potassium bicarbonate rinse solution is applied to the tooth surface. After about two minutes, calculus is hand scaled.
- additives can be applied to the tooth surface. In some of these embodiments, additives can be applied with component A and/or component B.
- the additives used in the method can include, but are not limited to, antiseptics and preservatives, antibiotics, flavoring materials, surfactants, abrasives, thickeners and binders, propellants, carriers, tartar control agents, calcium sequestrants, fluoride salts, and dyes.
- Suitable antiseptics and preservatives can include, but are not limited to, chlorhexidine and salts thereof, polyhexamethylene biguanide, octenidine, quaternary ammonium salts and polymers thereof, organic acids, chelating agents, for example, a calcium chelating agent (e.g., ethylenediaminetetraacetic acid (EDTA)), essential oils, and parabens.
- chelating agents for example, a calcium chelating agent (e.g., ethylenediaminetetraacetic acid (EDTA)), essential oils, and parabens.
- EDTA ethylenediaminetetraacetic acid
- antibiotics can include penicillin, tetracycline, minocycline, and the like. Examples of antibiotics can also include those described in U.S. Pat. No. 6,685,921 (Lawlor).
- flavoring materials can include artificial sweeteners, plant oils, and synthetic flavors.
- abrasives can include silica particles, synthetic inorganic particles, and synthetic or plant derived organic particles.
- Suitable surfactants can include those described in U.S. Pat. Pub. No. 2006/0051385 (Scholz). Examples of such surfactants include cationic surfactants, zwitterionic surfactants, nonionic surfactants, and anionic surfactants.
- thickeners can include glycerol, silica, cellulose-based polymers, plant gums (e.g., guar and xanthan gum), petroleum derived materials such as petrolatum, polyethylene glycols, polyvinyl pyrrolidone and copolymers thereof, polylactic acids, long chain fatty acid alcohols, and aery late polymers.
- Suitable binders can include those described in U.S. Pat. No. 8,647,608 (Y ang et al.).
- Suitable carriers can include those described in U.S. Pat. No. 8,647,608 (Y ang et al.).
- Carriers can include any alcohols suitable for use in a subject's oral cavity, including ethanol, isopropanol, and glycerol. Suitable dyes include those conventionally used in dental products. Examples of tartar control agents can include those described in U.S. Pat. No. 6,685,921 (Lawlor). Anti-tartar agents known for use in dental care products can include, but are not limited to phosphate. Phosphates can include pyrophosphates, polyphosphates, polyphosphonates, and mixtures thereof. Pyrophosphate salts can include the dialkali metal pyrophosphate salts, tetra-alkali metal pyrophosphate salts, and mixtures thereof. Examples of fluoride salts can include those described in U.S. Pat. No. 6,685,921 (Lawlor), U.S. Pat. No. 3,535,421 (Briner et al.), and U.S. Pat. No. 3,678,154 (Briner et al.).
- kits of removing calculus from a tooth of the present disclosure can include a component A including a metal ion selected from the group of lithium ion (Li + ), magnesium ion (Mg 2+ ), calcium ion (Ca 2+ ), a precursor thereto, and a combination thereof, an aprotic base having a pKb in water of greater than 15.4, or a precursor thereto; a component B including a bicarbonate ion or a precursor thereto; and instructions for applying components A and B to the tooth simultaneously or sequentially, thereby generating a gas to soften and/or loosen at least part of the calculus on the tooth, and for removing at least a part of the calculus from the tooth.
- component A and/or component B may further include one or more additives as described herein.
- Embodiment 1 is a method of removing calculus from a tooth comprising:
- component A comprises: a metal ion selected from the group of lithium ion (Li + ), magnesium ion (Mg 2+ ), calcium ion (Ca 2+ ), a precursor thereto, and a combination thereof; and an aprotic base having a pKb in water of greater than 15.4, or a precursor thereto;
- component B comprises a bicarbonate ion or a precursor thereto
- components A and B are applied simultaneously or sequentially to the tooth, thereby generating a gas to soften and/or loosen at least part of the calculus on the tooth;
- Embodiment 2 is the method of embodiment 1 wherein component A is applied before or after component B is applied.
- Embodiment 3 is the method of embodiment 1 or 2 wherein the metal ion and aprotic base of component A are provided by the same compound.
- Embodiment 4 is the method of any one of embodiments 1 to 3 wherein the metal ion and aprotic base of component A are provided by different compounds.
- component A could include lithium nitrate and sodium chloride.
- Component A is combined with component B, which contains a bicarbonate ion. The key is that the lithium ion, chloride ion, and bicarbonate ion are all present in that example.
- Embodiment 5 is the method of any one of embodiments 1 to 4 wherein the aprotic base of component A comprises triflate ion (OTf), iodide ion ( ⁇ ), perchlorate ion (CIO4 ), bromide ion (Br ), chloride ion (CI ), or a combination thereof.
- OTf triflate ion
- ⁇ iodide ion
- CIO4 perchlorate ion
- bromide ion Br
- chloride ion CI
- Embodiment 6 is the method of any one of embodiments 1 to 5 wherein the precursor of a metal ion of component A and/or the precursor of an aprotic base comprises a solid salt.
- Embodiment 7 is the method of embodiment 5 or 6 wherein component A comprises a lithium halide, a magnesium halide, a calcium halide, a sodium halide, a sodium triflate, a sodium perchlorate, or a combination thereof.
- Embodiment 8 is the method of embodiment 7 wherein component A comprises LiCl, MgC ⁇ , CaC3 ⁇ 4, or a combination thereof.
- Embodiment 9 is the method of any one of embodiments 1 to 8 wherein component A is a solid when applied to the tooth that is at least partially dissolved upon mixing component A and component B on the tooth.
- Embodiment 10 is the method of any one of embodiments 1 to 9 wherein component A is an aqueous solution when applied to the tooth.
- Embodiment 11 is the method of embodiment 10 wherein the aqueous solution comprises greater than 1 M of a metal salt comprising the metal ion. In some embodiments, the aqueous solution comprises greater than 1 M of the metal ion and greater than 1 M of an aprotic base.
- Embodiment 12 is the method of embodiment 10 or 11 wherein the aqueous solution comprises a saturated solution of the metal ion, or the metal ion at a concentration up to the solubility limit of the metal salt.
- Embodiment 13 is the method of any one of embodiments 1 to 12 wherein the precursor of a bicarbonate ion of component B comprises a solid salt.
- Embodiment 14 is the method of any one of embodiments 1 to 12 wherein the precursor to a bicarbonate ion comprises a carbonate (e.g., a carbonate salt) and an acid, which can form the bicarbonate.
- a carbonate e.g., a carbonate salt
- Embodiment 15 is the method of any one of embodiments 1 to 14 wherein component B is a solid when applied to the tooth that is at least partially dissolved upon mixing component A and component B on the tooth.
- Embodiment 16 is the method of any one of embodiments 1 to 14 wherein component B is an aqueous solution when applied to the tooth.
- Embodiment 17 is the method of embodiment 16 wherein the aqueous solution comprises greater than 0.5 M of a bicarbonate ion.
- Embodiment 18 is the method of embodiment 16 or 17 wherein the aqueous solution comprises a saturated solution of the bicarbonate ion, or the bicarbonate ion at a concentration up to the solubility limit of the bicarbonate salt, or up to 3 M bicarbonate ion.
- Embodiment 19 is the method of any one of embodiments 1 to 18 wherein component B comprises potassium bicarbonate (KHCO3).
- Embodiment 20 is the method of any one of embodiments 2 to 19 wherein component A is applied at least 30 seconds before applying component B.
- Embodiment 21 is the method of any one of embodiments 2 to 20 wherein component A is applied for a period of less than 1 hour before applying component B.
- Embodiment 22 is the method of embodiment 21 wherein component A is applied for a period of less than 30 minutes before applying component B.
- Embodiment 23 is the method of embodiment 22 wherein component A is applied for a period of less than 1 minute before applying component B.
- Embodiment 24 is the method of embodiment 23 wherein component A is applied for a period of less than 30 seconds before applying component B.
- Embodiment 25 is the method of any one of embodiments 2 to 19 wherein component B is applied at least 30 seconds before applying component A.
- Embodiment 26 is the method of any one of embodiments 2 to 19 and embodiment 25 wherein component B is applied for a period of less than 1 hour before applying component A.
- Embodiment 27 is the method of embodiment 25 wherein component B is applied for a period of less than 30 minutes before applying component A.
- Embodiment 28 is the method of embodiment 27 wherein component B is applied for a period of less than 1 minute before applying component A.
- Embodiment 29 is the method of embodiment 28 wherein component B is applied for a period of less than 30 seconds before applying component A.
- Embodiment 30 is the method of any one of embodiments 1 to 29 wherein both component A and component B are each applied for a period of less than 1 hour.
- Embodiment 31 is the method of any one of embodiments 1 to 30 wherein the removing step occurs within 1 day after the applying steps.
- Embodiment 32 is the method of any one of embodiments 1 to 31 wherein the applying steps and removing step are all completed in less than 1 day.
- Embodiment 33 is the method of any one of embodiments 1 to 32 wherein at least a part of the calculus is removed by mechanical means.
- Embodiment 34 is the method of embodiment 33 wherein at least a part of the calculus is removed by mechanical means other than tooth brushing.
- Embodiment 35 is the method of embodiment 33 or 34 wherein at least a part of the calculus is removed by a dental scaler.
- Embodiment 36 is the method of any one of embodiments 1 to 35 wherein component A and component B are aqueous solutions when applied to the tooth and wherein the aqueous solution of component A comprises greater than 1 M of the metal ion and greater than 1 M of an aprotic base and the aqueous solution of component B comprises greater than 0.5 M of a bicarbonate ion.
- Embodiment 37 is a kit of parts for removing calculus from a tooth comprising:
- a component A comprising:
- a metal ion selected from the group of lithium ion (Li + ), magnesium ion (Mg 2+ ), calcium ion (Ca 2+ ), a precursor thereto, and a combination thereof; and
- an aprotic base having a pKb in water of greater than 15.4, or a precursor thereto;
- component B comprising a bicarbonate ion or a precursor thereto
- Embodiment 38 is the kit of parts of embodiment 37 wherein component A and/or component B further includes one or more additives.
- Embodiment 39 is the kit of parts of embodiment 38 wherein the one or more additives are selected from antiseptics and preservatives, antibiotics, flavoring materials, surfactants, abrasives, thickeners and binders, propellants, carriers, tartar control agents, calcium sequestrants, fluoride salts, and dyes.
- the one or more additives are selected from antiseptics and preservatives, antibiotics, flavoring materials, surfactants, abrasives, thickeners and binders, propellants, carriers, tartar control agents, calcium sequestrants, fluoride salts, and dyes.
- Embodiment 40 is the kit of parts of any one of embodiments 37 to 39 wherein component A and component B are aqueous solutions and wherein the aqueous solution of component A comprises greater than 1 M of the metal ion and greater than 1 M of an aprotic base and the aqueous solution of component B comprises greater than 0.5 M of a bicarbonate ion.
- Calcium chloride (CaC ) was obtained from EMD Millipore (Billerica, MA) and was dissolved into deionized water to prepare 3 M and saturated solutions.
- Lithium chloride LiCl was obtained from the Sigma-Aldrich Corporation (St. Louis, MO).
- Magnesium chloride (MgCh) was obtained from CalBiochem (San Diego, CA) and was dissolved into deionized water to prepare 1 M, 3 M and saturated solutions.
- Potassium bicarbonate was obtained from the Sigma-Aldrich Corporation and was dissolved in deionized water to prepare 0.5 M, 1 M, and 3 M solutions.
- Strontium nitrate was obtained from Alfa Aesar (Ward Hill, MA) and was dissolved into deionized water to prepare a saturated solution.
- Barium nitrate (Ba(N03)2) was obtained from Mallinckrodt (St. Louis, MO) and was dissolved into deionized water to prepare a saturated solution.
- Extracted human teeth containing multiple regions with calculus deposits (available from various suppliers such as enretec GmbH, Velten, Germany) were stored in 0.5-1.0 wt. % aqueous chloramine-T solution prior to use. To prepare the extracted teeth for calculus removal testing, each tooth was rinsed with deionized water. Hand scaling of calculus deposits as described in the following examples was performed using a universal (i.e., Columbia) curette commercially available from OSU G MND CO., LTD. (Korea).
- a region of calculus on an extracted tooth was treated with deionized water and then hand scaled. This was identified as the control region of the tooth.
- a region of calculus on an extracted tooth was treated with deionized water and then hand scaled. This was identified as the control region of the tooth.
- a region of calculus on an extracted tooth was treated with deionized water and then hand scaled. This was identified as the control region of the tooth.
- a region of calculus on an extracted tooth was treated with deionized water and then hand scaled. This was identified as the control region of the tooth.
- a region of calculus on an extracted tooth was treated with deionized water and then hand scaled. This was identified as the control region of the tooth.
- a region of calculus on an extracted tooth was treated with deionized water and then hand scaled. This was identified as the control region of the tooth.
- a region of calculus on an extracted tooth was treated with deionized water and then hand scaled. This was identified as the control region of the tooth.
- To a second unsealed region of calculus on the same tooth two drops of Sr(N03)2 (saturated solution), followed by the immediate application of two drops of KHCO3 (3 M). After waiting about 15 seconds, hand scaling of this region was performed. This was identified as the treatment region of the tooth. The process was repeated on a second tooth.
- a region of calculus on an extracted tooth was treated with deionized water and then hand scaled. This was identified as the control region of the tooth.
- a region of calculus on an extracted tooth was treated with deionized water and then hand scaled. This was identified as the control region of the tooth.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662410711P | 2016-10-20 | 2016-10-20 | |
| PCT/US2017/050056 WO2018075150A1 (en) | 2016-10-20 | 2017-09-05 | Methods and kits for removing calculus using a metal ion and bicarbonate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3528771A1 true EP3528771A1 (en) | 2019-08-28 |
| EP3528771B1 EP3528771B1 (en) | 2023-08-23 |
Family
ID=59887411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17768326.5A Active EP3528771B1 (en) | 2016-10-20 | 2017-09-05 | Methods and kits for removing calculus using a metal ion and bicarbonate |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12514792B2 (en) |
| EP (1) | EP3528771B1 (en) |
| JP (1) | JP2019535674A (en) |
| CN (1) | CN109843249A (en) |
| AU (1) | AU2017347538B2 (en) |
| BR (1) | BR112019008013A2 (en) |
| WO (1) | WO2018075150A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3233036B1 (en) | 2014-12-15 | 2023-01-25 | 3M Innovative Properties Company | Kits for removing calculus |
| BR112018076904B1 (en) | 2016-06-22 | 2022-02-08 | 3M Innovative Properties Company | METHOD AND KIT OF PARTS FOR CALCULATION REMOVAL OF A TOOTH |
| WO2018075149A1 (en) | 2016-10-20 | 2018-04-26 | 3M Innovative Properties Company | Methods and kits for removing calculus using a non-enzymatic, hydrogen peroxide decomposition catalyst |
| BR112019008013A2 (en) | 2016-10-20 | 2019-10-01 | 3M Innovative Properties Company | Methods and Kits to Remove Calculus Using a Metal Ion and Baking |
| EP4419062A1 (en) | 2021-10-20 | 2024-08-28 | Solventum Intellectual Properties Company | Composition and process for treating a disorder in the oral cavity of a mammal |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1482367A (en) * | 1922-12-28 | 1924-01-29 | Harvey G Elledge | Production of carbon dioxide |
| US3372125A (en) | 1965-11-15 | 1968-03-05 | Peter Strong & Company Inc | Denture cleanser |
| US3678154A (en) | 1968-07-01 | 1972-07-18 | Procter & Gamble | Oral compositions for calculus retardation |
| US3535421A (en) | 1968-07-11 | 1970-10-20 | Procter & Gamble | Oral compositions for calculus retardation |
| BE755331A (en) | 1969-09-01 | 1971-02-01 | Blendax Werke Schneider Co | ORAL AND DENTAL CARE PRODUCTS |
| GB1468144A (en) * | 1972-06-12 | 1977-03-23 | Halstead J | Dental method composition |
| US3932605A (en) | 1972-06-12 | 1976-01-13 | Jaroslav Vit | Dental treatment |
| US3998945A (en) | 1972-06-12 | 1976-12-21 | National Patent Development Corporation | Dental treatment |
| GB1492660A (en) * | 1975-10-13 | 1977-11-23 | Colgate Palmolive Co | Dentifrices |
| AU510235B2 (en) | 1975-12-22 | 1980-06-19 | Johnson & Johnson | Denture cleanser tablet |
| AT371338B (en) | 1979-10-30 | 1983-06-27 | Gergely Gerhard | CLEANING TABLET FOR DENTAL PROSTHESES |
| JPS5950280B2 (en) | 1980-10-24 | 1984-12-07 | 花王株式会社 | Enzyme bleach composition |
| US4487757A (en) | 1981-12-28 | 1984-12-11 | Colgate-Palmolive Company | Dispensing container of toothpaste which effervesces during toothbrushing |
| ZA829380B (en) * | 1981-12-28 | 1984-08-29 | Colgate Palmolive Co | Dispensing container of effervescent toothpaste |
| US4528180A (en) | 1983-03-01 | 1985-07-09 | Schaeffer Hans A | Dental preparation, article and method for storage and delivery thereof |
| US4436720A (en) * | 1983-03-04 | 1984-03-13 | Pakhomov Gennady N | Granulated treatment-and-prophylactic dental preparation possessing anticarious effect |
| US4522805A (en) | 1983-06-08 | 1985-06-11 | Norman Gordon | Tooth and gum dentifrice |
| US4894220A (en) | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
| FR2627517B1 (en) | 1988-02-24 | 1990-10-12 | Sandoz Sa | PROCESS FOR BLEACHING TEXTILE MATERIALS WITH ENZYMATIC DESTRUCTION OF EXCESS PEROXIDE |
| US5817294A (en) | 1990-11-02 | 1998-10-06 | Arnold; Michael J. | Plaque adsorbent oral composition and method |
| JPH04217618A (en) * | 1990-12-19 | 1992-08-07 | Kao Corp | Composition for oral cavity |
| US5385727A (en) * | 1993-05-19 | 1995-01-31 | Church & Dwight Co., Inc. | Dentifrices containing zinc oxide particles and sodium bicarbonate |
| US5403578A (en) | 1994-02-08 | 1995-04-04 | Gordon; Norman | Stable tooth and gum dentifrice with microencapsulation and method for making same |
| EP0691124A1 (en) | 1994-07-07 | 1996-01-10 | Sara Lee/DE N.V. | Mouth care products |
| WO1997007777A1 (en) | 1995-08-15 | 1997-03-06 | Robert Eric Montgomery | Peroxidase-activating oral compositions |
| US6331291B1 (en) | 1996-05-30 | 2001-12-18 | William R. Glace | Dentifrice gel/paste compositions |
| WO1998043603A1 (en) | 1997-03-27 | 1998-10-08 | The Procter & Gamble Company | Dual phase oral compositions containing a basic phase and an acidic phase |
| US6108850A (en) | 1997-06-03 | 2000-08-29 | Mclaughlin; Gerald | Accelerated method and instrumentation for whitening teeth |
| WO1998057653A1 (en) | 1997-06-17 | 1998-12-23 | Novo Nordisk A/S | An oral care composition comprising a bacillus pullulanase and a dextranase |
| CA2341640A1 (en) | 1998-07-02 | 2000-01-13 | Chaitan Khosla | Methods for making polyketides using altered pks |
| FR2787778B1 (en) | 1998-12-23 | 2001-02-23 | Cleani | COMPOSITIONS COMPRISING A PERSON IN ANHYDROUS MEDIUM, AND USES THEREOF |
| US6207139B1 (en) | 1999-04-16 | 2001-03-27 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Anti-tartar dental product and related method |
| US6685921B2 (en) | 2000-10-25 | 2004-02-03 | The Procter & Gamble Company | Dental care compositions |
| US6379654B1 (en) | 2000-10-27 | 2002-04-30 | Colgate Palmolive Company | Oral composition providing enhanced tooth stain removal |
| US6485709B2 (en) | 2001-01-23 | 2002-11-26 | Addent Inc. | Dental bleaching gel composition, activator system and method for activating a dental bleaching gel |
| US6946142B2 (en) | 2001-06-23 | 2005-09-20 | Lg Household & Healthcare Ltd. | Multi-layer patches for teeth whitening |
| WO2003007719A1 (en) * | 2001-07-18 | 2003-01-30 | National Institute Of Advanced Industrial Science And Technology | Cleansers, cleansing system, bleaching agents and compositions for enviromental conservation |
| JP5329734B2 (en) | 2001-08-15 | 2013-10-30 | スリーエム イノベイティブ プロパティズ カンパニー | Curable self-supporting structure and method |
| US20040120900A1 (en) | 2002-12-20 | 2004-06-24 | Peter Arsenault | Intraoral calculus dissolving gel composition |
| US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
| US20050196348A1 (en) | 2004-03-03 | 2005-09-08 | Constantine Georgiades | Stabilized peroxide compositions |
| US7530808B2 (en) | 2004-03-10 | 2009-05-12 | Cao Group, Inc | Binary dental bleaching using switch-closable double barrel syringe |
| US9028852B2 (en) | 2004-09-07 | 2015-05-12 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
| EP1814509A2 (en) | 2004-11-09 | 2007-08-08 | Discus Dental Impressions, Inc. | Dental whitening systems comprising transition metal salt activator |
| US9271902B2 (en) | 2005-02-15 | 2016-03-01 | Martin S. Giniger | Whitening system capable of delivering effective whitening action |
| CN100531682C (en) * | 2005-03-10 | 2009-08-26 | 沃辉有限公司 | Sound wave toothbrush and swing shaft motor thereof |
| US20070254260A1 (en) * | 2005-12-02 | 2007-11-01 | Alden Wayne S Iv | Oral care compositions, methods, devices and systems |
| JP4922779B2 (en) * | 2006-02-06 | 2012-04-25 | サンメディカル株式会社 | Tooth bleaching composition |
| EP2180873B1 (en) | 2007-07-25 | 2018-04-11 | 3M Innovative Properties Company | Therapeutic dental composition for use in the inhibition of biofilm formation in the oral cavity. |
| US7740479B2 (en) | 2007-10-03 | 2010-06-22 | Ultradent Products, Inc. | Activating brush tip applicators for dental bleaching compositions |
| US20090220919A1 (en) | 2008-02-28 | 2009-09-03 | Jen-Chang Yang | Dental Bleaching Gel Composition Containing Vegetative Enzymes |
| WO2009109533A1 (en) | 2008-03-07 | 2009-09-11 | Basf Se | Bleach catalysts and their use as teeth whitening agents |
| RU2432620C1 (en) * | 2010-02-17 | 2011-10-27 | Государственное образовательное учреждение высшего профессионального образования "Омский государственный университет им. Ф.М. Достоевского" | Method of analysis of calculus formation sensitivity to glucose |
| US20110305738A1 (en) | 2010-06-09 | 2011-12-15 | Ladizinsky Daniel A | Oxygenating Oral Compositions |
| JP5824061B2 (en) | 2010-10-27 | 2015-11-25 | スリーエム イノベイティブ プロパティズ カンパニー | Dental composition comprising semi-crystalline resin and nanocluster filler |
| EP2645987B1 (en) | 2010-12-01 | 2015-11-04 | B.R.A.I.N. Biotechnology Research And Information Network AG | Novel catalases |
| JP5469194B2 (en) | 2011-05-02 | 2014-04-09 | 日東電工株式会社 | Adhesive, adhesive layer, and adhesive sheet |
| US9089479B2 (en) * | 2011-05-03 | 2015-07-28 | Fenwal, Inc. | Medium, solutions and methods for the washing, culturing and storage of white blood cells |
| US20140294742A1 (en) | 2011-10-10 | 2014-10-02 | Ul Tradent Products, Inc. | Anti-plaque dental compositions |
| CN102499778B (en) * | 2011-10-19 | 2015-03-11 | 五河克菱保健科技有限公司 | Multifunctional artificial tooth nursing sheet |
| CN104173197A (en) | 2014-08-24 | 2014-12-03 | 秦俊远 | Efficient tooth whitening strip |
| EP3233036B1 (en) | 2014-12-15 | 2023-01-25 | 3M Innovative Properties Company | Kits for removing calculus |
| JP6470833B2 (en) | 2015-03-04 | 2019-02-13 | 富士フイルム株式会社 | Touch panel adhesive sheet, touch panel laminate, capacitive touch panel |
| BR112018076904B1 (en) | 2016-06-22 | 2022-02-08 | 3M Innovative Properties Company | METHOD AND KIT OF PARTS FOR CALCULATION REMOVAL OF A TOOTH |
| WO2018075149A1 (en) | 2016-10-20 | 2018-04-26 | 3M Innovative Properties Company | Methods and kits for removing calculus using a non-enzymatic, hydrogen peroxide decomposition catalyst |
| BR112019008013A2 (en) | 2016-10-20 | 2019-10-01 | 3M Innovative Properties Company | Methods and Kits to Remove Calculus Using a Metal Ion and Baking |
| US11046817B2 (en) * | 2017-12-11 | 2021-06-29 | The Procter & Gamble Company | Compositions comprising multi-valent cations and phosphono-phosphate containing polymers |
-
2017
- 2017-09-05 BR BR112019008013-9A patent/BR112019008013A2/en not_active Application Discontinuation
- 2017-09-05 AU AU2017347538A patent/AU2017347538B2/en not_active Ceased
- 2017-09-05 WO PCT/US2017/050056 patent/WO2018075150A1/en not_active Ceased
- 2017-09-05 JP JP2019521150A patent/JP2019535674A/en active Pending
- 2017-09-05 US US16/342,824 patent/US12514792B2/en active Active
- 2017-09-05 EP EP17768326.5A patent/EP3528771B1/en active Active
- 2017-09-05 CN CN201780064857.1A patent/CN109843249A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN109843249A (en) | 2019-06-04 |
| JP2019535674A (en) | 2019-12-12 |
| AU2017347538A1 (en) | 2019-05-02 |
| US20190231649A1 (en) | 2019-08-01 |
| AU2017347538B2 (en) | 2020-07-23 |
| WO2018075150A1 (en) | 2018-04-26 |
| EP3528771B1 (en) | 2023-08-23 |
| US12514792B2 (en) | 2026-01-06 |
| BR112019008013A2 (en) | 2019-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12514792B2 (en) | Methods and kits for removing calculus using a metal ion and bicarbonate | |
| EP3528772B1 (en) | Methods and kits for removing calculus using a non-enzymatic, hydrogen peroxide decomposition catalyst | |
| RU2015129106A (en) | ORGANIC CARE COMPOSITIONS CONTAINING A ZIN COMPLEX WITH AMINO ACID AND HALOGENIDE | |
| RU2015123751A (en) | Mouthwash with Zinc Amino Acid Halide | |
| RU2015123679A (en) | ORAL CARE PRODUCTS CONTAINING A FOUR-BASIC ZINC-AMINO ACID-HALOGENIDE COMPLEX | |
| RU2015123707A (en) | Oral Care Products Including Zinc Oxide and Trimethylglycine | |
| RU2015123653A (en) | ORGANIC CARE GEL CONTAINING ZINC AND AMINO ACIDS COMPLEX | |
| RU2016148244A (en) | TOOTH CARE CONTAINING AN AMINO ACID ZINC AND PHOSPHATES COMPLEX | |
| JP2014210798A5 (en) | ||
| FI75734C (en) | Munsköljningslösning. | |
| RU2018142540A (en) | ORGANIC CARE COMPOSITION | |
| RU2013111534A (en) | Means for caring for the oral cavity, methods for its use and production | |
| JP2013542171A (en) | How to clean and whiten teeth at the same time | |
| JP7292037B2 (en) | Method and kit for removing tartar | |
| US20200230038A1 (en) | Methods and kits for removing calculus | |
| Gavrila et al. | Comparative study regarding the effect of different remineralizing products on primary and permanent teeth enamel caries lesions | |
| JP2012504113A (en) | New composition | |
| RU2008893C1 (en) | Method for medicinal-prophylaxis treatment of dental enamel | |
| WO2022109261A2 (en) | Dental calculus removal | |
| KR102674595B1 (en) | Dental kits and ways to prevent caries | |
| JPS6019889B2 (en) | Oral rinses to prevent tartar formation or remove plaque | |
| RU2272661C1 (en) | Toothpaste for therapeutic and prophylactic treatment of enamel and method for treating of enamel | |
| Patel et al. | COMPARISON OF FLUORIDE VARNISH AND SILVER DIAMINE FLUORIDE ON ENAMEL REMINERALIZATION AROUND ORTHODONTIC BRACKETS BONDED WITH RESIN MODIFIED GLASS IONOMER CEMENT: An in vitro Study. | |
| WO2021059215A2 (en) | Oral care composition | |
| Stoleriu et al. | The use of arginine containing toothpastes in dental hard tissues remineralization |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20190429 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20200430 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 6/79 20200101ALI20230216BHEP Ipc: A61K 8/19 20060101ALI20230216BHEP Ipc: A61Q 11/00 20060101ALI20230216BHEP Ipc: A61K 8/20 20060101AFI20230216BHEP |
|
| INTG | Intention to grant announced |
Effective date: 20230310 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017073116 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230818 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20230823 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1601734 Country of ref document: AT Kind code of ref document: T Effective date: 20230823 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231124 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231223 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231226 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231123 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231223 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231124 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
| RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602017073116 Country of ref document: DE Owner name: SOLVENTUM INTELLECTUAL PROPERTIES CO. (N.D.GES, US Free format text: FORMER OWNER: 3M INNOVATIVE PROPERTIES COMPANY, SAINT PAUL, MN, US |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230905 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017073116 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20230930 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230905 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230905 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20231123 |
|
| 26N | No opposition filed |
Effective date: 20240524 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230905 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231023 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231123 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231123 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170905 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170905 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20250820 Year of fee payment: 9 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |